Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
Immune thrombocytopenia (ITP) is a complex autoimmune disease characterized by low platelet counts. The pathogenesis of ITP remains unclear although both antibody‐mediated and/or T cell‐mediated platelet destruction are key processes. In addition, impairment of T cells, cytokine imbalances, and t...
Main Authors: | Anne Zufferey, Rick Kapur, John W. Semple |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/6/2/16 |
Similar Items
-
Response to rituximab in children and adults with immune thrombocytopenia (ITP)
by: Emily M. Harris, et al.
Published: (2021-08-01) -
Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
by: Deirdra R. Terrell, et al.
Published: (2020-11-01) -
Understanding Immune Thrombocytopenia: Looking Out of the Box
by: Alexandra Schifferli, et al.
Published: (2021-06-01) -
The Role of Leptin in Childhood Immune Thrombocytopenia (ITP): An Anti-Inflammatory Agent?
by: Iason Thomas, et al.
Published: (2021-07-01) -
Emerging Concepts in Immune Thrombocytopenia
by: Maurice Swinkels, et al.
Published: (2018-04-01)